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1. Introduction
  Herbal remedies have become popular for the treatment 
of various airway diseases[1-3]. Herbalists in Nigeria 
use the aqueous leaf extract of Bryophyllum pinnatum
(B. pinnatum) (Lam.) Oken (= Kalanchoe pinnata Pers) 
for the prophylaxis of asthma and treatment of cough. It 
belongs to the family Crassulaceae and has many common 
names including air plant, Canterbury bells, cathedral 
bells, life plant, Mexican love plant, miracle plant and 
resurrection plant. It is found in many parts of the world 
perhaps because of its ease of cultivation. Phytoconstituents 
of the leaves include flavonoids, saponins, tannins and 
alkaloids[4,5]. Vitamins including ascorbic acid, riboflavin, 
thiamine, niacin and minerals such as calcium, zinc and 
phosphorus are also present in the leaves[4].
  The various scientifically validated medicinal properties 
have been listed in our previous reports[6,7]. These 
properties include antimicrobial, antifungal, antiulcer, 
antihypertensive, tocolytic, antidiabetic, hepatoprotective, 
anti-inflammatory, analgesic, and wound healing. Other 
reported properties include anti-tumour, sedative, 
muscle relaxant and effectiveness in the treatment of 
leishmaniasis.  The aqueous leaf extract has been shown to 
attenuate responses of isolated tracheal smooth muscles to 
spasmogens such as histamine and carbachol[6]. Acute and 
sub-acute toxicity assessments have been carried out on 
the plant[7].
  The aqueous leaf extract of the plant is used by herbal 
practitioners in Nigeria and other parts of Africa for the 
treatment of cough and as a prophylactic medicine for 
asthma. In Benin City, Nigeria, the leaves are boiled, 
filtered through a clean white cloth and the yield 
reconstituted for daily oral use by asthmatic patients. The 
leaves are also warmed over fire and the juice expressed 
from them is taken for the treatment of cough. The present 
study was designed to evaluate the anti-asthmatic and 
antitussive properties of the extract in rodent species. 
Objective: To evaluate the antiasthmatic and antitussive properties of the aqueous leaf extract 
of Bryophyllum pinnatum (B. pinnatum) (BP) Lam. Methods: Ovalbumin-sensitized guinea 
pigs which were treated with BP for 21 consecutive days were exposed to 0.2% histamine aerosol 
in a glass chamber. Mucus viscosity, white blood cell and lymphocyte counts and tracheal 
wall morphometry were measured. Bouts of cough were counted pre and post acute exposure 
of extract-treated (×7 d) guinea pigs to 7.5% citric acid aerosol in a chamber. Phenol red 
expectoration was estimated in mice after 7 d of daily administration of BP. Results: Doses of 
200 and 400 mg/kg/day (×21 d) BP significantly increased the time for guinea pigs to experience 
preconvulsive dyspnoea. BP and salbutamol (0.5 mg/kg/day × 21 d) reduced mucus viscosity in 
the sensitized group to values comparable with controls. White blood cell, lymphocyte counts and 
tracheal morphometry were not significantly altered. Both doses of BP also significantly reduced 
the bouts of cough but only 400 mg/kg/day significantly inhibited the amount of phenol red 
secreted. Conclusions: BP has demonstrated antiasthmatic and antitussive properties in these 
rodent models. These properties may underscore its use in Nigerian ethnomedicine.
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2. Materials and methods
2.1. Plant material
  Leaves of B. pinnatum not exposed to herbicides were 
collected from a suburb of Benin City, Nigeria, in August 
2010. A herbarium specimen of the plant with voucher 
number FHI 107762 exists at the Forest Research Institute of 
Nigeria. As reported previously[6,7] adulterants were picked 
out and the leaves were thoroughly rinsed in tap water. 
The leaves (2 kg) were boiled for one hour in 4 L of distilled 
water, allowed to cool and then filtered two times with a 
clean white cloth.  The resulting extract was concentrated 
in a rotary evaporator before drying in an oven at 40 曟 over 
24 h (yield = 3.6% w/w). The extract (BP) was then stored in 
amber-coloured bottles at 4 曟. 
2.2. Animals 
  Adult guinea pigs of either sex weighing (350-400 g) were 
obtained from the Animal Unit, Ambrose Alli University, 
Ekpoma, Nigeria. Mice of either sex weighing 22-30 g were 
in-bred in the Animal House, Department of Pharmacology 
and Toxicology, Faculty of Pharmacy, University of Benin, 
Benin City, Nigeria. The animals were housed in standard 
plastic cages (males separate from females) and allowed 
free access to pellets (Bendel Feeds and Flour Mill Ltd, 
Ewu, Nigeria) and tap water. They were exposed to day-
night light cycle and room temperature (27.0 依 2.0) 曟. The 
animals were handled according to standard protocols for 
the use of laboratory animals[8]. The study was approved 
by institutional ethical committee on the use of animals for 
experiments.
2.3. Anti-asthmatic experiments
2.3.1. Exposure to histamine aerosol 
  Guinea pigs were randomly allotted to five groups: A -non-
sensitized + 2 mL/kg/day distilled water; B- sensitized + 2 
mL/kg/day distilled water; C-sensitized + 200 mg/kg/day 
BP; D-sensitized + 400 mg/kg/day BP; and E-sensitized 
+ 0.5 mg/kg/day salbutamol. Animals were sensitized by 
single administration of 100 mg/kg (i.p.) ovalbumin on the 
first day and another 50 mg/kg (i.m.) the following day[9]. 
Treatment with water, extract or salbutamol was per os for 21 
consecutive days.
  One hour after the last dose (on the 21st day), response to 
an allergen was measured in the guinea pigs[10]. The animals 
were exposed to 0.2% histamine aerosol using Omron 
compressor nebulizer (USA) at a rate of 0.4 mL/min and 
particle size 5 毺m, in a glass chamber (60 cm 伊 36 cm伊 60 
cm) until preconvulsive dyspnoea was observed. 
2.3.2. Measurement of white blood cell and lymphocyte 
counts
  After exposure to histamine aerosol the animals were 
allowed 1 h of full recovery before they were anaesthetized 
with chloroform vapour and 0.5 mL blood samples were 
withdrawn from the abdominal aorta. Total white blood cells 
(WBC) and the lymphocytes (LYM) were analyzed by use of 
an automated blood analyzer (QBC Autoread Plus, UK). The 
blood samples were first pipetted into QBC capillary tubes 
and spun in a parafuge centrifuge (Becton Dickson, UK) for
5 min and read by means of the autoread analyzer[11].
2.3.3. Measurement of mucus viscosity
  Mucus viscosity was measured by flushing 2 cm length 
of trachea (from the point of thoracic bifurcation towards 
the pharynx). The pieces of trachea were held upright and 
flushed each with 2 mL of normal saline over 5 min. The 
effluent fluid was then subjected to viscosity test. In brief, 
the effluent fluid was shaken thoroughly and 1 mL was 
withdrawn into a 1 mL syringe which was then held in place 
with a retort stand. The plunger of the syringe was carefully 
withdrawn and the time it took for the whole fluid to drain 
was noted[11]. Viscosity was expressed as mL/s.
2.3.4. Tissue histology and morphometry
  The remaining parts of each trachea and the lungs were 
stored in 10% formosaline. The tissues were later dehydrated, 
embedded in paraffin wax and sectioned (5 毺m thickness) 
with a microtome. They were stained with hematoxylin 
and eosin, and viewed under an Olympus CH10 optical 
microscope at 伊100 or 伊400 magnification. Photomicrographs 
of the tissues were obtained at 伊 400 magnification by use 
of an Olympus CH10 optical microscope fitted with a 12.2 
megapixels Samsung ES17 digital camera. Micrographs of the 
tracheae (under uniform magnification) were printed out and 
the thickness of the tracheal wall and cartilage measured 
with a ruler. 
2.4. Antitussive experiments
2.4.1. Exposure to citric acid aerosol
  Guinea pigs were exposed to 7.5% citric acid aeroso[10,12] 
using the Omron compressor nebulizer (rate 0.4 mL/min 
and particle size 5 毺m) in the glass chamber (described 
above) for 5 min. Animals with cough bouts of (15 依 5) were 
randomly allotted into three groups and administered 200, 
400 mg/kg/day BP and 25 mg/kg/day codeine phosphate 
orally respectively. The animals were re-exposed to 7.5% 
citric acid aerosol after 1 h and the bouts of cough recorded.
2.4.2. Phenol red expectoration
  In the phenol red expectorant method[13], mice were 
randomly allotted into five groups: A-distilled water control; 
B-200 mg/kg/day BP; C-400 mg/kg/day BP; D-sodium 
cromoglycate (50 mg/kg/day); and E-bromhexine (15 mg/kg). 
Except for sodium cromoglycate which was administered 
i.p., other drugs and BP were administered per os. Treatment 
was for seven consecutive days except for bromhexine
(15 mg/kg) which was administered to the fifth group on the 
7th day.  NH4Cl (5 mg/kg p.o.) was administered 1 h after the 
7th-day dose and then followed with phenol red dye (0.5 g/
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kg i.p.) after 30 min. Each trachea (2 cm) was excised after 
cervical dislocation of each mouse and then placed in a 
solution of 1 mL normal saline + 0.1 mL 1 N NaOH to stabilize 
the pH. Absorbance of dye secreted from the trachea was 
measured at 460 nm with a UV-Visible spectrophotometer 
(Cecil Instrument Limited, Milton Technical Centre, 
England). 
2.5. Statistics 
   Data are presented as mean 依 SEM (standard error of the 
mean) and n represents the number of guinea pigs or mice 
per group. Data from experimental groups were compared 
by use of one-way ANOVA with Tukey post hoc. All data 
were analyzed using GraphPad Prism software (UK). P<0.05 
indicates statistically significant difference.
3. Results
3.1. Anti-asthmatic effects
  Table 1 shows that 400 mg/kg/day 伊 21 BP significantly 
(40.8%, P<0.005) inhibited histamine-induced bronchospasm 
as indicated by the time taken for the animals to experience 
preconvulsive dyspnoea, compared with sensitized non-
extract treated group but not when compared with control 
(distilled water treated) group. The time taken to experience 
preconvulsive dyspnoea was also prolonged in 200 mg/
kg/day 伊 21 BP (23.2%, P<0.05) and 0.5 mg/kg/day 伊 21 
salbutamol (33%, P<0.05) treated groups when compared with 
sensitized non-extract treated group.
  The total WBC and lymphocytes counts were not 
significantly altered across the groups. The mean WBC count 
was highest in the ovalbumin sensitized group and lowest 
in the control (distilled water treated) group. Lymphocyte 
counts paralleled WBC counts but values were also not 
significantly different across the groups. Mucus viscosity 
was significantly (P<0.05) reduced by both doses of extract 
when compared with the sensitized non-extract treated 
group (Table 2). The mean value for the extract treated group 
was comparable with that of distilled water control group. 
Salbutamol significantly reduced mucus viscosity (P<0.05) 
when compared with sensitized only group.
  Morphometry of the tracheal rings shows that mean values 
for tracheal wall and cartilage thickness were highest in the 
sensitized group that were not given the extract but lowest 
in the salbutamol treated group. Values are however not 
significantly different (Table 3). 
  Representative photomicrographs of the lungs are shown 
in Figure 1. The lungs from control group contained patent 
bronchioles and clear airways (plate A) while the lungs from 
ovalbumin sensitized guinea pigs contained mucus plugs 
and interstitial infiltrates of eosinophils (plate B). The lungs 
from 400 mg/kg/day 伊 21 BP treated group and 0.5 mg/kg/day 
伊 21 salbutamol treated group all showed varying degrees 



















Figure 1. Photomicrographs of lungs of guinea pigs treated for 21 
consecutive days.
(A) Distilled water control showing patent bronchiole (栺), well 
inflated alveoli (栻) and interstitial infiltrates of inflammatory 
cells. (B) Ovalbumin-sensitized but distilled water treated showing 
bronchiolar mucus plug (栺) and interstitial infiltrates of eosinophils. 
(C) B. pinnatum (400 mg/kg/day) treated showing markedly dilated 
bronchiole (栺) with luminal necrotic debris and mild infiltrates 
of inflammatory cells (栻). (D) Salbutamol (0.5 mg/kg/day) treated 
showing dilated bronchiole (栺), well inflated alveoli (栻) and mild 
infiltrates of inflammatory cells. A, C, D (H & E, 伊 400); B, (H & E, 伊 
100).
3.2. Anti-tussive effects
  Table 4 shows that BP at dose of 200 mg/k/day 伊 7 reduced 
cough bouts from (12.4依1.3) to (4.6依0.7) (63% inhibition, 
P<0.05) and 400 mg/kg/day × 7 reduced cough bouts from 
(14.2 暲1.8) to (7.2依1.2) (49.3%, P<0.05). The standard drug 
(codeine phosphate) administered for 7 days reduced the 
bouts of cough from (14.8依1.6) to (3.0依0.4) (80% inhibition, 
P<0.05). There was no significant difference in the bouts of 
cough by the distilled water control group.
  Compared with distilled water control, BP doses of 200 and 
400 mg/kg/day 伊 7 significantly (P<0.05) reduced phenol 
red secretion in mice tracheae by 31.94% and 38.89% 
respectively. Sodium cromoglycate reduced dye secretion by 
29.01% when compared to distilled water group. Bromhexine, 
a known mucolytic and bronchitis drug increased dye 
concentration by 8.03% compared to distilled water group 
(Table 5).
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4. Discussion
  The data from this study suggest that the aqueous leaf 
extract of B. pinnatum (BP) may prevent acute asthmatic 
attacks in human. The dose of 400 mg/kg/day for 21 d was 
comparable with 0.5 mg/kg/day of salbutamol in protecting 
guinea pigs from histamine-induced preconvulsive 
dypsnoea. A previous study has shown that BP does not 
possess direct tracheal smooth muscle relaxant property but 
attenuates responses of the isolated guinea tracheal rings 
to spasmogens such as histamine and acetylcholine[6]. It 
therefore seems that the protection offered the sensitized 
animals may have been by prevention of airway smooth 
muscle spasms. While the mechanisms involved are not 
certain, BP is known to possess antioxidant properties. 
  BP contains flavonoids among others[4,5]. Flavonoids as 
secondary plant metabolites have been associated with 
potent antioxidant properties that underlie their use in the 
management of chronic obstructive airway disorders such 
as asthma[14-17]. Flavonoids also inhibit Ca2+ release and 
utilization mechanisms in smooth muscles[18,19]. Reduced 
mucus viscosity is valuable in the therapy of asthma since 
increased secretion and viscosity impede airflow in the 
respiratory tree[20,21]. This property has been demonstrated 
Table 1
Effect of B. pinnatum extract administered for 21 consecutive days on time taken for occurrence of preconvulsive dyspnoea in guinea pigs.
Groups Dose(Quantity/kg/day) Preconvulsion time(s) Protection(%)
Control               2 mL (DW)    135.40依4.85 -
Sens + BP 200 mg       176.30依27.24* 23.20
Sens + BP 400 mg       228.70依23.53* 40.80
Sens               2 mL (DW)     86.50依6.68 -56.53
Sens +Sal 0.5 mg      202.20依55.45*   33.04
*P<0.05 vs. Sens. DW: distilled water; Sens: sensitized; BP: aqueous leaf extract of B. pinnatum; Sal: salbutamol, n = 5-7 per group.
Table 2
WBC lymphocyte and mucus viscosity in guinea pigs treated for 21 consecutive days with aqueous leaf extract of B. pinnatum.
Groups Dose(Quantity/kg/day) WBC counts(伊 103/毺L) Lymphocyte counts(伊 10
3/毺L) Mucus viscosity(伊 10
-3mL/s)
Control                2 mL (DW)   8.76依0.93 7.04依0.83   8.34依0.40*
Sens + BP 200 mg 10.92依3.19 8.03依2.14   8.37依0.39*
Sens + BP 400 mg   9.58依1.79 6.87依1.09   8.41依0.37*
Sens               2 mL (DW) 12.52依3.74 9.64依2.92  6.53依0.45
Sens +Sal 0.5 mg 11.28依1.15 8.02依0.70    8.83依0.11*
*P<0.05 compared with sens. DW: distilled water; Sens: sensitized; BP: aqueous leaf extract of B. pinnatum; Sal: salbutamol, n = 5-7 per group.
Table 3
Tracheal morphometry after 21 consecutive days of administering aqueous extract of B. pinnatum to guinea pigs.
Groups Dose (Quantity/kg/day) Tracheal wall thickness (cm) Cartilage thickness (cm)
Control               2 mL (DW)  18.67依2.40 13.83依1.88
Sens + BP 200 mg  19.08依1.24 14.50依0.85
Sens + BP 400 mg  21.00依0.58 11.25依1.93
Sensitized               2 mL (DW)  21.67依1.67 15.17依2.80
Sens +Sal 0.5 mg  17.58依1.57 13.00依1.29
Values in columns are not significantly different. DW: distilled water; Sens: sensitized; BP: aqueous leaf extract of B. pinnatum; Sal: salbutamol, 
n = 5 per group (伊 400 magnification).
Table 4
Effect of oral daily (伊 7) administration of B. pinnatum extract on citric acid-induced acute cough in guinea pigs.
Groups Dose(Quantity/kg/day) Cough bouts before Cough bouts after Inhibition of cough bouts (%)
Control 2 mL (DW) 11.50依0.87   10.00依1.68 13.04
BP 200 mg 12.40依1.25      4.60依0.68* 62.90
BP 400 mg 14.20依1.83      7.20依1.24* 49.30
Codeine PO4   25 mg 14.75依1.60       3.00依0.41* 79.66
*P<0.05 compared with values before treatment. DW: distilled water; BP: aqueous leaf extract of B. pinnatum. n = 5 per group.   
Table 5
Effect of oral daily (伊 7) administration of B. pinnatum extract on phenol red dye secretion in mice.
Groups Dose(Quantity/kg/day) Conc. of dye (毺g/mL) Inhibition of dye secretion (%)
Control               2 mL (DW)  12.96依2.72 -
BP 200 mg    8.82依1.46 31.94
BP 400 mg     7.92依1.74* 38.89
Na Cromoglycate            50 mg (i.p.)#    9.20依1.07 29.01
Bromhexine HCl 15 mg  14.00依2.22 -8.03
*P<0.05 compared with control. DW: distilled water; BP: aqueous leaf extract of B. pinnatum. #Administered on the 7th day. n = 5 per group.
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by BP in the sensitized group. 
  Sensitization with ovalbumin is a model of obstructive 
airway disease in which the airways become inflamed and 
hyper-responsive[22]. Ability of agents to inhibit responses by 
ovalbumin-sensitized guinea pigs often suggests usefulness 
in obstructive airway diseases. However sensitization with 
ovalbumin did not significantly increase tracheal wall/
cartilage thickness or the white blood cell/lymphocyte 
counts at the time of sacrifice. Although BP possesses anti-
inflammatory activity[6], the present data indicate that the 
protection of the guinea pigs did not depend on this as 
tracheal wall/cartilage thickness was comparable across 
the groups. Histological findings reveal that the indices are 
better in guinea pigs which were administered the extracts 
compared with those which were sensitized but not treated 
with either extract or salbutamol. Such positive indices include 
inflated alveolar sacs and absence of mucus in the airway. 
  Antitussive data from the present study indicate that BP 
reduces the number of bouts of cough and quantity of dye 
secreted by the trachea. The mechanisms which underlie 
cough reflex are complex and difficult to understand but are 
either peripheral or central[23,24]. With reduction in the mucus 
viscosity and secretion, airflow resistance is consequently 
reduced and irritation which would trigger cough is also 
reduced. While this effect is peripheral, the involvement 
of central mechanisms in the inhibition of the bouts of 
cough cannot be excluded since agents such as codeine act 
centrally[25,26]. Also, the involvement of peripheral sensory 
airway neuronal inhibition in the antitussive action of BP 
is not clear. These neurons have been the focus of new 
search for antitussive agents since the centrally acting ones 
that have been the gold standard for decades have serious 
adverse effects[23,27,28]. The findings from study suggest that 
BP may be helpful for irritant coughs due to hypersecretion 
by airway pathologies such as asthma and infections. 
  In conclusion this study has shown that BP possesses some 
anti-asthmatic and antitussive properties in rodent species 
which may underscore its use in ethnomedicine. 
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